Tag Archives: federal drug scheduling

Cannabis descheduling not one of pharma giant’s ‘core priorities’

Published: Feb 23, 2018, 5:17 pm • Updated: Feb 23, 2018, 5:31 pm By Alicia Wallace, The Cannabist Staff A pharmaceutical giant that once developed marijuana-based medicines won’t be advocating for the descheduling of cannabis anytime soon. Indianapolis-based Eli Lilly

DEA finalizing Schedule II status for synthetic THC drug Syndros

Published: Nov 21, 2017, 8:50 am • Updated: Nov 21, 2017, 9:36 am By Alicia Wallace, The Cannabist Staff The U.S. Drug Enforcement Administration this week will grant Schedule II status to a synthetic THC drug developed by a pharmaceutical

Congress members, veterans join forces in call for medical marijuana reforms

Published: Nov 2, 2017, 5:06 pm • Updated: Nov 2, 2017, 5:56 pm By Bruce Kennedy, The Cannabist Staff Veterans are adding their voices to the growing chorus calling for changes in marijuana research and legalization. A bipartisan group of

Skip to toolbar